Market Size – USD 6.76 Billion in 2020, Market Growth – at a CAGR of 1.4%, Market Trends – Rising number of clinical trials to understand the efficacy of heparin as a therapy for COVID-19

The global heparin market size is expected to reach USD 7.55 Billion in 2028 at a CAGR of 1.4% during the forecast period, according to the latest report by Reports and Data. Rising demand for heparin due to high prevalence of chronic conditions such as last-stage renal disease, atrial fibrillation, and cardiovascular diseases, increasing number of surgical procedures performed across the globe, and extensive RD activities to explore other clinical and therapeutic roles of heparin are key factors expected to drive market revenue growth over the forecast period. In addition, heparin is used for various off-label indications in hospitals and for treatment and prevention of venous thromboembolism events in post-surgical patients, and this is another factor expected to contribute to revenue growth of the market going ahead.

Top Companies Profiled in the Report Include:

Pfizer Inc.,

Dr. Reddy’s Laboratories Ltd.,

Teva Pharmaceutical Industries Ltd.,

Sanofi SA, B. Braun Melsungen AG,

GlaxoSmithKline PLC,

LEO Pharma A/S,

Aspen Holdings,

Fresenius SE Co. KGaA,

Viatris Inc.

To receive a sample copy of the global Heparin Market report, visit @ https://www.reportsanddata.com/download-summary-form/4154

Heparin Market Overview:

The pharma and healthcare industry has undergone a revolutionary change owing to the COVID-19 pandemic with individuals increasing their focus on health and wellness. Companies operating in the industry have invested heavily in clinical trials and research studies to develop medications to cater to the growing unmet clinical demand on a global level. Implementation of cutting-edge technology in healthcare sector and increasing investment in research and development have contributed significantly to revenue growth of the market in the recent past. In addition, availability of favorable health insurance and reimbursement policies have also positively impacted the healthcare sector with more and more individuals opting to get treatment at hospital and clinical facilities. Rapid development of novel drugs and pharmaceuticals, increasing incidence of lifestyle and chronic diseases, establishment of state-of-the-art healthcare facilities, and rising availability of over-the-counter medications have significantly contributed to the revenue growth of the market.  

Major Highlights of the Heparin Market Report:

• The Heparin Market analysis report offers an in-depth study of the potential market growth opportunities and challenges.
• The report dives deeper into the market and explains the dynamic factors bolstering market growth.
• The report deeply assesses the current, historical market size, market share, and revenue growth rates to offer accurate market projections for the forecast period.
• The report analyzes the Heparin Market presence across major regions of the world.
• It determines the production consumption capacities and demand supply dynamics of each regional market.
• The report further illustrates the intense competition among the key market players and highlights their effective business expansion plans and strategies.
• It provides company overview and SWOT analysis of each of the market players.

To receive a flat discount on the Heparin Market report, visit @ https://www.reportsanddata.com/discount-enquiry-form/4154

Key Regional Markets Studied in the Report:

• North America (U.S., Canada)
• Europe (U.K., Italy, Germany, France, Rest of EU)
• Latin America (Chile, Brazil, Argentina, Rest of Latin America)
• Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
• The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Additionally, the report consists a detailed analysis of the segmentation of the Heparin Market based on product types and end-use/application offered in the Heparin Market.

Product Type Outlook (Revenue, USD Billion; 2018-2028)

Unfractionated Heparin

Low Molecular Weight Heparin

Ultra-low Molecular Weight Heparin

Route of Administration (Revenue, USD Billion; 2018-2028)

Subcutaneous

Intravenous

Application Outlook (Revenue, USD Billion; 2018-2028)

Coronary Artery Disease

Venous Thromboembolism

Atrial Fibrillation

Renal Impairment

Others

Distribution Channel Outlook (Revenue, USD Billion; 2018-2028)

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

To know more about the Heparin Market report @ https://www.reportsanddata.com/press-release/global-heparin-market

Have A Look For Related Reports:

Intravenous (IV) Equipment Market - https://www.reportsanddata.com/report-detail/intravenous-iv-equipment-market

Short Bowel Syndrome Market - https://www.reportsanddata.com/report-detail/short-bowel-syndrome-market

Colonoscopy Bowel Preparation Drugs Market - https://www.reportsanddata.com/report-detail/colonoscopy-bowel-preparation-drugs-market

Homecare Pregnancy Test Kits Market - https://www.reportsanddata.com/report-detail/homecare-pregnancy-test-kits-market

Nucleic Acid Amplification Testing (NAAT) Market - https://www.reportsanddata.com/report-detail/nucleic-acid-amplification-testing-naat-market

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.

Contact Us:                       

John W

Head of Business Development

Reports and Data | Web: www.reportsanddata.com

Direct Line: +1-212-710-1370

E-mail: sales@reportsanddata.com